MD

Dr. Struck's research focuses on retinal function in albinism, particularly on the halted anatomical development and resulting visual impairment.

Dr. Jennifer Y. Li practices as an ophthalmologist in Sacramento, California and is associated with UC Davis Medical Center. She obtained her medical degree from Baylor College of Medicine and has been practicing for 11-20 years.

Dr. Mannis is Professor and Chair of the UC Davis Health System Eye Center. He specializes in corneal transplantation and external diseases of the eye. His research has included development of experimental antimicrobial agents and growth factors that affect the corneal wound healing rate, skin diseases that affect the eye, and outcomes of corneal transplants and artificial corneas. Dr. Mannis has authored over 125 publications and five books on topics relating to corneal surgery and disease.

Dr. Levin is a visual scientist and neuro-ophthalmologist at the University of Wisconsin School of Medicine and Public Health and the University of Montreal. He specializes in diseases of the optic nerve, and studies optic neuropathies and retinal ganglion cell death at the molecular, biochemical, and cellular level. He serves as a consultant to pharmaceutical companies in the areas of neuroprotection and its application to human disease, including glaucoma.

Dr. Kaufman is a Professor in the UW Department of Ophthalmology and Visual Sciences at the University of Wisconsin School of Medicine and Public Health. His research centers on studies of the physiology, pharmacology, morphology, cell biology, genetic manipulation, neural control, biomechanics and aging of the aqueous humor formation and drainage and accommodative mechanisms in the non-human primate, seeking to understand the pathophysiology and develop new therapies for the human diseases of glaucoma and presbyopia.

Dr. Hartigan-O'Connor is an Assistant Professor of Medicine at the University of California, Davis. His research is focused on mechanisms of tolerance and immune privilege, both in the adult eye and in the developing fetus. His most recent work focuses on resilience of retinal immune privilege to inflammatory insults and neovascularization, as well as the potential of immunosuppressive drugs to maintain privilege despite these challenges. His work has been published in leading journals including Science Translational Medicine and the Journal of Experimental Medicine.

Dr. Altaweel is an Assistant Professor of Ophthalmology at the University of Wisconsin School of Medicine and Public Health and Co-Director of the University of Wisconsin Department of Ophthalmology Fundus Photograph Reading Center. His clinical specialties include diseases and surgery of the retina and vitreous, and fundus interpretation. His research interests include clinical trials of drug efficacy as well as the scientific grading of retinal photographs and fluorescein angiograms.

Dr. Barney is an Associate Professor in the Department of Ophthalmology and Visual Sciences at the University of Wisconsin School of Medicine and Public Health. His clinical training is in all aspects of ocular immunology including uveitis and inflammatory disease of the anterior segment of the eye. His laboratory interests include the cellular signaling events on the ocular surface undergoing allergic reactions. He is a Principle Investigator on NIH funded research.

Dr. Danis is a practicing medical retina specialist, Professor of Ophthalmology and Visual Sciences at the University of Wisconsin-Madison and UW Fundus Photograph Reading Center (FPRC), Principle Investigator on more than a dozen industry and federally funded multicenter clinical trials, and Co-Founder and Chief Science Officer of EyeKor. Dr. Danis' preclinical research has employed a variety of animal models of intraocular angiogenesis, including laser-induced choroidal neovascularization, oxygen-induced retinopathy, and ischemia-induced retinal neovascularization.

Dr. Moshiri’s commitment to academic medicine is founded on his scientific interest in retinal genetics and retinal stem cell biology, and he pursues an active laboratory research program. His research background is in the embryonic development of the retina. Under the supervision of Professor Thomas A. Reh at the University of Washington in Seattle, Dr. Moshiri earned a Ph.D. in Neurobiology studying the genetic control of retinal stem cells during eye development. He applied these studies from the embryonic retina to replace retinal cells after injury in adult animals.